{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2019-10-17T17%3A50%3A51.473Z&answeringDeptId=17&min-answer.questionFirstAnswered.=2019-02-18T14%3A39%3A34.13Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?max-ddpCreated=2019-10-17T17%3A50%3A51.473Z&answeringDeptId=17&min-answer.questionFirstAnswered.=2019-02-18T14%3A39%3A34.13Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2019-10-17T17%3A50%3A51.473Z&answeringDeptId=17&min-answer.questionFirstAnswered.=2019-02-18T14%3A39%3A34.13Z&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&max-ddpCreated=2019-10-17T17%3A50%3A51.473Z&answeringDeptId=17&min-answer.questionFirstAnswered.=2019-02-18T14%3A39%3A34.13Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2019-10-17T17%3A50%3A51.473Z&answeringDeptId=17&min-answer.questionFirstAnswered.=2019-02-18T14%3A39%3A34.13Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2019-10-17T17%3A50%3A51.473Z&answeringDeptId=17&min-answer.questionFirstAnswered.=2019-02-18T14%3A39%3A34.13Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1150324", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1150324/answer", "answerText" : {"_value" : "

The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU.<\/p>

The Department, as part of our EU exit preparations, has analysed the supply chains of over 12,000 licensed medicines used by patients in the United Kingdom and close to half a million product lines of medical devices and clinical consumables with an EU/European Economic Area touchpoint. This approach means that the medicines and medical equipment used by people living with disabilities are included within our planning.<\/p>

We continue to implement a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:<\/p>

https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans<\/a>.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "dateOfAnswer" : {"_value" : "2019-10-22", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-22T15:31:09.83Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health Services: Disability"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the risks posed to people living with disabilities by a lack of availability of (a) medicines and (b) essential medical equipment in the event of the UK leaving the EU without a withdrawal agreement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"} } , "tablingMemberConstituency" : {"_value" : "North Norfolk"} , "tablingMemberPrinted" : [{"_value" : "Norman Lamb"} ], "uin" : "1607"} , {"_about" : "http://data.parliament.uk/resources/1150353", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1150353/answer", "answerText" : {"_value" : "

All paediatric audiology services are required to record paediatric screening, assessment data, diagnosis and treatment data onto the national online database called \u2018Smart for hearing\u2019. This is co-ordinated centrally by the Newborn Hearing Screening team in the National Screening Office at Public Health England.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"} } , "answeringMemberConstituency" : {"_value" : "Gosport"} , "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"} , "dateOfAnswer" : {"_value" : "2019-10-24", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-24T11:46:52.85Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Hearing Impairment: Children"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether audiology Departments are required to collect data on the number of children identified as having hearing loss.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/350", "label" : {"_value" : "Biography information for Sir John Hayes"} } , "tablingMemberConstituency" : {"_value" : "South Holland and The Deepings"} , "tablingMemberPrinted" : [{"_value" : "Sir John Hayes"} ], "uin" : "1546"} , {"_about" : "http://data.parliament.uk/resources/1150373", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1150373/answer", "answerText" : {"_value" : "

Public Health England has not made an assessment of the effect of the Soft Drinks Industry Levy (SDIL) on the level of sugar consumption.<\/p>

The National Diet and Nutrition Survey is used to monitor trends in consumption of sugary soft drinks and sugar intakes. Data covering the period when the SDIL was introduced will be published in 2020.<\/p>

<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"} } , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"} , "answeringMemberPrinted" : {"_value" : "Jo Churchill"} , "dateOfAnswer" : {"_value" : "2019-10-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-25T13:02:17.937Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Sugar: Consumption"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has on the impact of the sugar tax on trends in the level of sugar consumption.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/373", "label" : {"_value" : "Biography information for Sir David Davis"} } , "tablingMemberConstituency" : {"_value" : "Haltemprice and Howden"} , "tablingMemberPrinted" : [{"_value" : "Mr David Davis"} ], "uin" : "1558"} , {"_about" : "http://data.parliament.uk/resources/1150375", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1150375/answer", "answerText" : {"_value" : "

The childhood obesity plan recognises that convenience food products high in fat, salt or sugar can lead to weight gain, which in turn increases the risk of heart disease, type 2 diabetes, stroke and some cancers. High levels of sugar intake also increase the risk of tooth decay.<\/p>

<\/p>

Many of the measures in the three chapters of our childhood obesity plan will have an impact on improving diet and reducing obesity across all age groups. These include the soft drinks industry levy, sugar reduction and wider calorie reformulation programme, restricting promotions and calorie labelling in restaurants which will improve our eating habits and reduce the amount of sugar we consume.<\/p>

<\/p>

<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"} } , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"} , "answeringMemberPrinted" : {"_value" : "Jo Churchill"} , "dateOfAnswer" : {"_value" : "2019-10-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-25T13:03:14.513Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Fast Food: Health Hazards"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect on public health of the availability of convenience food products.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/373", "label" : {"_value" : "Biography information for Sir David Davis"} } , "tablingMemberConstituency" : {"_value" : "Haltemprice and Howden"} , "tablingMemberPrinted" : [{"_value" : "Mr David Davis"} ], "uin" : "1560"} , {"_about" : "http://data.parliament.uk/resources/1150376", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1150376/answer", "answerText" : {"_value" : "

The National Health Service is working with Genomics England to ensure the security of personal data created by genomic sequencing through the new pipeline for Whole Genome Sequencing in the NHS.<\/p>

<\/strong><\/p>

Genomics England has adopted a multi-layered approach to delivering cyber security and data protection for data generated from sequencing. The approach ensures that Genomics England data capture systems remain secure and are appropriately protected from external threats. Genomics England has engaged with the Department, NHS Digital and the National Cyber Security Centre to review the Genomics England Security Strategy and Policy and is working towards formal Cyber Security Accreditation during 2020.<\/p>

<\/strong><\/p>

In April 2018, the Department launched the Data Security and Protection Toolkit. This covers the key data security and data protection requirements for health and social care organisations. Organisations can self-assess against it to demonstrate that they are meeting information governance requirements.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"} } , "answeringMemberConstituency" : {"_value" : "Gosport"} , "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"} , "dateOfAnswer" : {"_value" : "2019-10-24", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-24T15:10:12.713Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Genomics: Data Protection"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the security of personal data created by genomic sequencing.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/373", "label" : {"_value" : "Biography information for Sir David Davis"} } , "tablingMemberConstituency" : {"_value" : "Haltemprice and Howden"} , "tablingMemberPrinted" : [{"_value" : "Mr David Davis"} ], "uin" : "1561"} , {"_about" : "http://data.parliament.uk/resources/1150386", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1150386/answer", "answerText" : {"_value" : "

The Department is working with Public Health England (PHE), NHS England and NHS Improvement and other stakeholders to deliver a comprehensive vaccine and immunisation strategy this autumn. The strategy will set out a clear vision for maintaining and developing England\u2019s world-leading immunisation programme over the next 10 years and beyond.<\/p>

Actions planned or underway to increase the uptake of childhood vaccination include:<\/p>

- Strengthening the role of local immunisation coordinators \u2013 healthcare professionals that promote vaccine uptake, particularly in under-served groups, by supporting areas with low uptake and tailoring specific local interventions to under-vaccinated communities;<\/p>

- Updating NHS.uk to ensure availability of National Health Service-approved, evidence-based and trusted advice on vaccines; and<\/p>

- A review of general practitioner vaccinations and immunisation standards, funding, and procurement to incentivise improved immunisation coverage.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"} } , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"} , "answeringMemberPrinted" : {"_value" : "Jo Churchill"} , "dateOfAnswer" : {"_value" : "2019-10-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-25T12:55:10.3Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle (a) declining rates of childhood vaccination and (b) anti-vaccine misinformation.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1405", "label" : {"_value" : "Biography information for Mark Field"} } , "tablingMemberConstituency" : {"_value" : "Cities of London and Westminster"} , "tablingMemberPrinted" : [{"_value" : "Mark Field"} ], "uin" : "1599"} , {"_about" : "http://data.parliament.uk/resources/1150388", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1150388/answer", "answerText" : {"_value" : "

The England Infected Blood Support Scheme (EIBSS) currently makes provision for ex gratia<\/em> one-off payments to eligible spouses, civil partners and long-term partners for individuals meeting qualifying criteria.<\/p>

<\/p>

The EIBSS also makes provision to help with the costs of bringing up children of an infected beneficiary in the form of an income top-up payment. This is a discretionary monthly payment to increase household income to help with general living costs. These are means-tested payments for dependants who are defined as children of an infected beneficiary up to the age of 18 years, or up to 21 if in full-time education.<\/p>

<\/p>

In July 2017 the then Prime Minister announced the establishment of the Infected Blood Enquiry. This statutory inquiry chaired by Sir Brian Langstaff, will examine why men, women and children in the United Kingdom were given infected blood and/or infected blood products and the impact on their families. The Inquiry will consider the nature and the adequacy of the treatment, care and support (including financial assistance) and the Government will carefully consider any recommendations made.<\/p>

<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1481", "label" : {"_value" : "Biography information for Ms Nadine Dorries"} } , "answeringMemberConstituency" : {"_value" : "Mid Bedfordshire"} , "answeringMemberPrinted" : {"_value" : "Ms Nadine Dorries"} , "dateOfAnswer" : {"_value" : "2019-10-24", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-24T15:47:42.777Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Blood: Contamination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, for what reasons parents and children of people who have died after being infected by contaminated blood products do not receive on-going financial support.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4673", "label" : {"_value" : "Biography information for Jo Platt"} } , "tablingMemberConstituency" : {"_value" : "Leigh"} , "tablingMemberPrinted" : [{"_value" : "Jo Platt"} ], "uin" : "1790"} , {"_about" : "http://data.parliament.uk/resources/1150408", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1150408/answer", "answerText" : {"_value" : "

The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients throughout the United Kingdom that our plans should ensure the uninterrupted supply of medicines and medical products, including those for use in the treatment of epilepsy, once we have left the EU.<\/p>

The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:<\/p>

https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans<\/a><\/p>

We have been working closely with suppliers to monitor over 300 different epilepsy medicines provided by almost 50 companies and we are pleased to see many are holding stockpiles far beyond the six weeks\u2019 additional buffer we requested. We also know that the vast majority of those suppliers with lower levels of stockpiles have already taken action to re-route their supply chains away from the Channel short straits crossings where applicable.<\/p>

<\/p>

The Department, alongside NHS England and NHS Improvement, is ensuring that there is regular communication with frontline NHS organisations and stakeholders in the health and social care sector regarding our EU exit preparations. NHS England and NHS Improvement have also been holding EU exit roadshows in the lead up to 31 October.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "dateOfAnswer" : {"_value" : "2019-10-22", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-22T11:18:05Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Epilepsy: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure people living in the London Borough of Southwark with epilepsy can continue to get the medication they need in the event of the UK leaving the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/150", "label" : {"_value" : "Biography information for Baroness Harman"} } , "tablingMemberConstituency" : {"_value" : "Camberwell and Peckham"} , "tablingMemberPrinted" : [{"_value" : "Ms Harriet Harman"} ], "uin" : "1533"} , {"_about" : "http://data.parliament.uk/resources/1150410", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1150410/answer", "answerText" : {"_value" : "

Pre-exposure prophylaxis (PrEP) is currently provided in England through the three year PrEP Impact Trial. Participation in the trial is on a voluntary basis and it is for clinics and local authorities to decide the number of allocated places they can accept.<\/p>

The Department is continuing to work closely with NHS England and NHS Improvement, Public Health England and local authorities to plan for a seamless transition from the PrEP Impact Trial to routine commissioning from April 2020.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"} } , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"} , "answeringMemberPrinted" : {"_value" : "Jo Churchill"} , "dateOfAnswer" : {"_value" : "2019-10-25", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "1768"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-25T13:08:36.387Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "HIV Infection: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will commit to commencing routine commissioning of PrEP from April 2020.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4615", "label" : {"_value" : "Biography information for Lloyd Russell-Moyle"} } , "tablingMemberConstituency" : {"_value" : "Brighton, Kemptown"} , "tablingMemberPrinted" : [{"_value" : "Lloyd Russell-Moyle"} ], "uin" : "1767"} , {"_about" : "http://data.parliament.uk/resources/1150411", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1150411/answer", "answerText" : {"_value" : "

Pre-exposure prophylaxis (PrEP) is currently provided in England through the three year PrEP Impact Trial. Participation in the trial is on a voluntary basis and it is for clinics and local authorities to decide the number of allocated places they can accept.<\/p>

The Department is continuing to work closely with NHS England and NHS Improvement, Public Health England and local authorities to plan for a seamless transition from the PrEP Impact Trial to routine commissioning from April 2020.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"} } , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"} , "answeringMemberPrinted" : {"_value" : "Jo Churchill"} , "dateOfAnswer" : {"_value" : "2019-10-25", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "1767"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-25T13:08:36.327Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "HIV Infection: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what progress is being made towards the routine commissioning of PrEP.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4615", "label" : {"_value" : "Biography information for Lloyd Russell-Moyle"} } , "tablingMemberConstituency" : {"_value" : "Brighton, Kemptown"} , "tablingMemberPrinted" : [{"_value" : "Lloyd Russell-Moyle"} ], "uin" : "1768"} ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&max-ddpCreated=2019-10-17T17%3A50%3A51.473Z&answeringDeptId=17&min-answer.questionFirstAnswered.=2019-02-18T14%3A39%3A34.13Z", "page" : 0, "startIndex" : 1, "totalResults" : 4524, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }